113 related articles for article (PubMed ID: 3548084)
1. [Cyclosporin A as a diabetogenic cofactor].
Lanzer G; Beaufort F; Kolb H; Semmelrock HJ; Ziak E; Borkenstein J; Zeichen R; Pogglitsch H
Wien Med Wochenschr; 1986 Nov; 136(21-22):557-9. PubMed ID: 3548084
[TBL] [Abstract][Full Text] [Related]
2. Progress in segmental neoprene-injected pancreas transplantation. Advantages and disadvantages of using Cyclosporin A.
Traeger J; Dubernard JM; Bosi E; Gelet A; El Yafi S; Secchi A; Cardozo C; Touraine JL
Proc Eur Dial Transplant Assoc; 1983; 20():705-10. PubMed ID: 6361763
[TBL] [Abstract][Full Text] [Related]
3. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
[TBL] [Abstract][Full Text] [Related]
4. Kidney transplantation in Cebu.
Maguad RA; Simporios AS
Transplant Proc; 1992 Oct; 24(5):1811-2. PubMed ID: 1412857
[No Abstract] [Full Text] [Related]
5. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
Citro M; Gadaleta G; Gamba Ansaldi S; Molinatti M; Salvetti E; Bruni B
Ann Osp Maria Vittoria Torino; 1983; 26(1-6):108-42. PubMed ID: 6388459
[TBL] [Abstract][Full Text] [Related]
6. Diabetogenic effect of cyclosporin.
Bending JJ; Ogg CS; Viberti GC
Br Med J (Clin Res Ed); 1987 Feb; 294(6569):401-2. PubMed ID: 3101896
[TBL] [Abstract][Full Text] [Related]
7. HLA-A, -B and -C specificities in insulin dependent diabetes mellitus in the Egyptian population.
Guirguis FK; Sawy ME; Khalil S; Mikhail MM; Zaky A; Helmy MA; Helmy-Khalil S
Ann Biol Clin (Paris); 1985; 43(3):233-7. PubMed ID: 3875301
[TBL] [Abstract][Full Text] [Related]
8. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
Svenson K; Bohman SO; Hällgren R
Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
[TBL] [Abstract][Full Text] [Related]
9. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
[No Abstract] [Full Text] [Related]
10. HLA and insulin-dependent juvenile diabetes mellitus.
Májský A; Dvoráková L
Czech Med; 1983; 6(3):152-8. PubMed ID: 6416792
[TBL] [Abstract][Full Text] [Related]
11. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
Kisch ES; Yust I
Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
[No Abstract] [Full Text] [Related]
13. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
Feutren G
Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
[No Abstract] [Full Text] [Related]
14. [Cyclosporin in kidney transplantation].
Land W; Castro LA; Hillebrand G; Klare B; Illner WD; Fornara P
Internist (Berl); 1985 Sep; 26(9):549-52. PubMed ID: 3905675
[No Abstract] [Full Text] [Related]
15. [The HLA system and diabetes mellitus].
Witt S
Z Gesamte Inn Med; 1981 Jan; 36(2):38-42. PubMed ID: 7222846
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of cyclosporin A (CsA) in insulin-dependent diabetes in children and analysis of the secondary effects].
Lévy-Marchal C; Tubiana-Rufi N; Czernichow P
Journ Annu Diabetol Hotel Dieu; 1987; ():187-97. PubMed ID: 3613364
[No Abstract] [Full Text] [Related]
17. The HLA association of insulin-dependent (type I) diabetes mellitus.
Bertrams J
Behring Inst Mitt; 1984 Jul; (75):89-99. PubMed ID: 6333238
[TBL] [Abstract][Full Text] [Related]
18. Gallstone formation after pancreas and/or kidney transplantation: an analysis of risk factors.
van Petersen AS; van der Pijl HW; Ringers J; Lemkes HH; de Fijter HW; Masclee AA
Clin Transplant; 2007; 21(5):651-8. PubMed ID: 17845641
[TBL] [Abstract][Full Text] [Related]
19. A brief review of histopathology in kidney transplant recipients immunosuppressed with cyclosporin A.
Mihatsch MJ
Scand J Urol Nephrol Suppl; 1985; 92():95-7. PubMed ID: 3914070
[TBL] [Abstract][Full Text] [Related]
20. Japanese Multicenter Trial of Cyclosporine in Renal Transplantation: overall results and analysis of the factors influencing graft survival rate.
Ochiai T; Toma H; Takagi H; Oka T; Ishibashi M; Kashiwabara H; Fukao K; Ota K; Hashimoto I; Sonoda T
Transplant Proc; 1987 Apr; 19(2):2961-6. PubMed ID: 3551242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
